Gufic Biosciences Limited — Board Meeting, 30-05-2025: Outcome of Board Meeting

Gufic Biosciences has announced a board meeting on May 30, 2025, approving the audited consolidated financial results for the quarter and year ended March 31, 2025. Revenue reached Rs. 819.8 Cr, with net profit at Rs. 69.93 Cr, down from Rs. 86.14 Cr last year. A final dividend of Re. 0.10/share (10%) was declared. New appointments include M/s. Poddar & Co. as Cost Auditors and M/s. Manish Ghia & Associates as Secretarial Auditors for five years. The company approved additional investments of up to Rs. 1 Cr each in Veira Life FZE (Dubai) and Gufic Ireland Limited and subscribed to a rights issue in Gufic Prime Pvt Ltd.